Research led by the Centenary Institute in Sydney has found a brand new target for treating drug resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body’s blood clotting system to weaken our immune systems.
Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat,
costing up to $250,000 to treat a single case in Australia. Scientists at the Centenary Institute have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune
Using the zebrafish model of tuberculosis, the researchers used fluorescent microscopy to observe the build-up of clots and activation of platelets around sites of infection . Senior author and head of the Centenary’s Immune-Vascular Interactions laboratory, Dr Stefan Oehlers, says “the zebrafish gives us literal insight into disease processes by watching cells interacting in real time”.
Following their hunch that these platelets were being tricked by the infection into getting in the way of the body’s immune system, the researchers treated infections with anti-platelet drugs, including widely available aspirin, and were able to prevent hijacking and allow the body to control infection better.
Dr Elinor Hortle, lead author of the paper published in The Journal of Infectious Diseases, and Research Officer in Centenary’s Immune-Vascular Interactions laboratory says “This is the first
time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant
There are over 1.2 million Australians living with latent tuberculosis, a non-infectious form of TB that puts them at risk of developing the active disease. “Our study provides more crucial evidence
that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives,” says Dr Hortle.
Video 1 – Green platelets
zooming around the
vasculature of a zebrafish
embryo. Note some platelets
stick to red macrophages
infected by blue bacteria
Video 2 – Zoomed in version
of video 1 with visible blood
Green platelets sticking to
red blood vessels next to
sites of infection by blue
bacteria. Pathogenic platelets
are the green cells that stick
next to the bacteria for a few
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Tuberculosis killed 20,000 in N Korea last year - WHO reporton October 17, 2019 at 8:35 pm
SEOUL, Oct 18 -- Some 20,000 people are estimated to have died from tuberculosis in North Korea last year, up 25 per cent from a year earlier, reported Yonhap News Agency, quoting a recent World ...
- Tuberculosis cases hit record U.S. low, on decline globallyon October 17, 2019 at 6:48 pm
The United States last year recorded its lowest number of cases of tuberculosis, and many other countries also reported a decrease in cases of the deadly infectious disease. For 2018, the U.S.
- Tuberculosis Infections Declining, But Not Fast Enough Among Poor, Marginalised: UN Health Agencyon October 17, 2019 at 1:08 pm
UNITED NATIONS, Oct 17 2019 (IPS) - A staggering 1.5 million people died from tuberculosis (TB) last year, the UN health agency said on Thursday, in an appeal for far greater funding and political ...
- Hope Restored in the Kingdom of Eswatini as Tuberculosis Incidence Reduced by More Than Halfon October 17, 2019 at 7:35 am
Twana Bhembe witnessed the devastating effects of tuberculosis (TB) when her sister died from the disease in 2011. That was before she and her husband were each diagnosed with the disease, a year ...
- Tuberculosis Drugs Market Growth by 2024: Revenue, Gross Margin and Market Shares, Demands, Types, Industry Demandson October 17, 2019 at 7:30 am
Oct 17, 2019 (Industry News Wire via COMTEX) -- Tuberculosis Drugs Market Summary 2019 : Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, ...
- Wily tuberculosis bacteria can vary its diet to infect you longeron October 15, 2019 at 6:20 am
Worldwide, approximately one in four people is infected by Mycobacterium tuberculosis and while overall New Zealand has relatively low rates of TB, Māori and Pacific people are eight times more likely ...
- Doctors Without Borders presses Johnson & Johnson to slash price of tuberculosis drugon October 14, 2019 at 4:03 pm
Doctors Without Borders is calling on Johnson & Johnson to halve the price of a lifesaving tuberculosis drug, called bedaquline, to make it more accessible to patients around the world. Currently, a ...
- Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Raon October 14, 2019 at 8:14 am
Global Tuberculosis Report 2018 (World Health Organization, 2018). 2. Zak, D. E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312–2322 (2016).
- Protest At J&J In New Brunswick For Cheaper Tuberculosis Drugon October 11, 2019 at 10:28 am
On Oct. 10, Doctors Without Borders called on Johnson & Johnson to lower the price of its life-saving tuberculosis medicine bedaquiline . (Provided by Doctors Without Borders) NEW BRUNSWICK, NJ — ...
- Scientists solve 3-D structure of 'nanomachine' that makes tuberculosis virulenton October 9, 2019 at 10:02 am
An international team headed by Óscar Llorca at the Spanish National Cancer Research Centre (CNIO), and the group led by Sebastian Geibel at the University of Würzburg (Germany), report an accurate ...
via Bing News